Migliazza A, Bosch F, Komatsu H, Cayanis E, Martinotti S, Toniato E, Guccione E, Qu X, Chien M, Murty V V, Gaidano G, Inghirami G, Zhang P, Fischer S, Kalachikov S M, Russo J, Edelman I, Efstratiadis A, Dalla-Favera R
Institute of Cancer Genetics, Columbia University, New York, New York 10032, USA.
Blood. 2001 Apr 1;97(7):2098-104. doi: 10.1182/blood.v97.7.2098.
Deletions of the 13q14 chromosome region are associated with B-cell chronic lymphocytic leukemia (B-CLL) and several other types of cancer, suggesting the presence of a tumor suppressor gene. In previous studies the minimal region of deletion (MDR) was mapped to a less than 300-kilobase (kb) interval bordered by the markers 173a12-82 and 138G4/1.3R. For the identification of the putative tumor suppressor gene, the entire MDR (approximately 347 kb) has been sequenced, and transcribed regions have been identified by exon trapping, EST-based full-length complementary DNA cloning, database homology searches, and computer-assisted gene prediction analyses. The MDR contains 2 pseudogenes and 3 transcribed genes: CAR, encoding a putative RING-finger containing protein; 1B4/Leu2, generating noncoding transcripts; and EST70/Leu1, probably representing another noncoding gene (longest open reading frame of 78 codons). These genes have been sequenced in 20 B-CLL cases with 13q14 hemizygous deletion, and no mutations were found. Moreover, no somatic variants were found in the entire MDR analyzed for nucleotide substitutions by a combination of direct sequencing and fluorescence-assisted mismatch analysis in 5 B-CLL cases displaying 13q14-monoallelic deletion. The nondeleted allele of the CAR and EST70/Leu1 genes was expressed in B-CLL specimens, including those with monoallelic loss, whereas no expression of 1B4/Leu2 was detectable in B-CLL, regardless of the 13q14 status. These results indicate that allelic loss and mutation of a gene within the MDR is an unlikely pathogenetic mechanism for B-CLL. However, haplo-insufficiency of one of the identified genes may contribute to tumorigenesis. (Blood. 2001;97:2098-2104)
13q14染色体区域的缺失与B细胞慢性淋巴细胞白血病(B-CLL)及其他几种癌症相关,这表明存在一个肿瘤抑制基因。在先前的研究中,最小缺失区域(MDR)被定位到一个小于300千碱基(kb)的区间,其边界为标记173a12 - 82和138G4/1.3R。为了鉴定假定的肿瘤抑制基因,已对整个MDR(约347 kb)进行了测序,并通过外显子捕获、基于EST的全长互补DNA克隆、数据库同源性搜索以及计算机辅助基因预测分析来鉴定转录区域。MDR包含2个假基因和3个转录基因:CAR,编码一种假定的含RING指结构域的蛋白质;1B4/Leu2,产生非编码转录本;以及EST70/Leu1,可能代表另一个非编码基因(最长开放阅读框为78个密码子)。已对20例发生13q14半合子缺失的B-CLL病例中的这些基因进行了测序,未发现突变。此外,在5例显示13q14单等位基因缺失的B-CLL病例中,通过直接测序和荧光辅助错配分析相结合的方法对整个MDR进行核苷酸替代分析,未发现体细胞变异。CAR和EST70/Leu1基因的非缺失等位基因在B-CLL标本中表达,包括那些单等位基因缺失的标本,而无论13q14状态如何,在B-CLL中均未检测到1B4/Leu2的表达。这些结果表明,MDR内一个基因的等位基因缺失和突变不太可能是B-CLL的致病机制。然而,所鉴定基因之一的单倍体不足可能有助于肿瘤发生。(《血液》。2001年;97:2098 - 2104)